|
|
Other links at Articles > Diabetes and Endocrinology |
| 1. |
FDA Safety Changes: Comtan, Stalevo, Tasmar, Symmetrel, Xenical, Casodex
|
|
|
The FDA has approved safety labeling revisions for entacapone tablets, levodopa/carbidopa/entacapone tablets, tolcapone tablets, amantadine HCl syrup and tablets, orlistat, and bicalutamide. Medscape Medical News
|
|
|